Enovis Corp - Company Profile
Powered by 
All the sales intelligence you need on Enovis Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Enovis Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Enovis Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Enovis Corp (Enovis), formerly Colfax Corp, is a medical technology company that provides products and services for musculoskeletal health, joint reconstruction, vascular health, and pain management. The company is also focused on developing clinically differentiated solutions. Its portfolio of products includes rigid and soft orthopedic bracing, hot and cold therapy, therapeutic shoes and inserts, bone growth stimulators, vascular therapy systems, and other metals and metal alloys. The company serves commercial and governmental customers in the US and other countries. It has manufacturing, assembling, warehousing, and engineering facilities in Europe, Asia, South America, and the Middle East. Enovis is headquartered in Wilmington, Delaware, the US.
Headquarters
United States of America
Address
2711 Centerville Road, Suite 400, Wilmington, Delaware, 19808
Website
www.enovis.com
Telephone
1 302 2529160
No of Employees
7,802
Industry
Medical Equipment
Ticker Symbol & Exchange
ENOV (NYSE)
Revenue (2024)
$2.2B
6.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-43.5%
(2024 vs 2023)
Market Cap*
$1.4B
Net Profit Margin (2024)
XYZ
-34.5%
(2024 vs 2023)
* As of and is in US$
Enovis Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Bracing and Supports: | Rehabilitation | DJO |
| Ligament Bracing | Aftermarket Service | Enovis |
| Cloud Connected Bracing | Bone Growth Stimulation | Creating Better Together |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Regulatory Approval | In September, the company announced that the US Food and Drug Administration cleared an expanded indication for its Spinalogic bone growth stimulator to include use as an adjunct after primary anterior cervical discectomy and fusion on two motion segments from C4 to C7, in addition to its lumbar fusion indication. |
| 2025 | Divestiture | In October, the company sold its Dr. Comfort diabetic shoe business to Promus Equity Partners for US$60 million. |
| 2025 | New Products/Services | In January, the company introduced Enovis Medical Education. |
Competitor Comparison
| Key Parameters | Enovis Corp | Stryker Corp | DePuy Synthes Inc | Zimmer Biomet Holdings Inc | Embla Medical hf |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | Iceland |
| City | Wilmington | Portage | Warsaw | Warsaw | Reykjavik |
| State/Province | Delaware | Michigan | Indiana | Indiana | - |
| No. of Employees | 7,802 | 56,000 | - | 17,000 | 4,192 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Damien McDonald | Director; Chief Executive Officer | Executive Board | 2025 | 61 |
| Sharon Wienbar | Chair | Executive Board | 2016 | 64 |
| Phillip B. Berry | Chief Financial Officer; Senior Vice President | Senior Management | 2023 | 47 |
| Bradley J. Tandy | Chief Legal Officer; Senior Vice President | Senior Management | 2019 | 67 |
| Oliver Engert | Chief Administrative Officer | Senior Management | 2026 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer